设为首页收藏本站

中国病毒学论坛|我们一直在坚持!

 找回密码
 立即注册

QQ登录

只需一步,快速开始

搜索
热搜: 活动 交友 discuz
查看: 2560|回复: 2
打印 上一主题 下一主题

[留学] 宾夕法尼亚大学医学院招病毒学博后

[复制链接]

119

帖子

57

学分

799

金币

VIP荣誉会员

Rank: 9Rank: 9Rank: 9Rank: 9

积分
57
跳转到指定楼层
楼主
发表于 2015-5-22 21:29:40 | 只看该作者 回帖奖励 |倒序浏览 |阅读模式
本帖最后由 bigben446 于 2015-5-23 20:36 编辑

Description        

A Postdoc position is available in a multidisciplinary virology laboratory in the Department of Microbiology at University of Pennsylvania School of Medicine. The focus of the laboratory is to study how the oncogenic DNA tumor viruses such as human papillomavirus (HPV) and Merkel cell polyomavirus (MCV) interact with their host cells to cause cancer. Various projects are available, involving studies of 1) the antiviral strategies to abrogate the HPV-host interaction, 2) MCV oncogenic mechanism, and 3) DNA tumor viruses and host immune responses.

Qualifications        

We are seeking creative and highly motivated individuals capable of executing research independently. A strong background in biochemistry, cell biology, or virology is desirable. We encourage individuals from underrepresented racial and ethnic groups, and individuals from socially, culturally, economically, or educationally disadvantaged backgrounds to apply.

Contact        Interested individuals should send a cover letter, curriculum vitae to:

Jianxin You, Ph.D.
University of Pennsylvania School of Medicine
Department of Microbiology
201C Johnson Pavilion, 3610 Hamilton WalkPhiladelphia, PA 19104-6076, USA
Email: jianyou@mail.med.upenn.edu


条件优秀的申请者,可不受上述条件限制。

分享到:  QQ好友和群QQ好友和群 QQ空间QQ空间 腾讯微博腾讯微博 腾讯朋友腾讯朋友
收藏收藏 分享分享 支持支持 反对反对

15

帖子

22

学分

2143

金币

病毒学院中学生

Rank: 3Rank: 3Rank: 3

积分
22
沙发
发表于 2015-5-25 10:52:36 | 只看该作者
I just look around

88

帖子

30

学分

193

金币

病毒学院中学生

Rank: 3Rank: 3Rank: 3

积分
30
板凳
发表于 2015-8-17 11:56:33 | 只看该作者
好想出国
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

QQ|论坛App下载|Archiver|小黑屋|中国病毒学论坛    

GMT+8, 2024-4-29 00:31 , Processed in 0.110259 second(s), 27 queries .

Powered by Discuz! X3.2

© 2001-2013 Comsenz Inc.

快速回复 返回顶部 返回列表